These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20230234)

  • 1. Bioinformatics for biodefense: challenges and opportunities.
    Valdivia-Granda WA
    Biosecur Bioterror; 2010 Mar; 8(1):69-77. PubMed ID: 20230234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing for Biodefense: Biothreat Detection, Forensics, and the Clinic.
    Minogue TD; Koehler JW; Stefan CP; Conrad TA
    Clin Chem; 2019 Mar; 65(3):383-392. PubMed ID: 30352865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodefense Oriented Genomic-Based Pathogen Classification Systems: Challenges and Opportunities.
    Valdivia-Granda WA
    J Bioterror Biodef; 2012 Mar; 3(1):1000113. PubMed ID: 25587492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodefense Policy Analysis-A Systems-based Approach.
    DiEuliis D; Rao V; Billings EA; Meyer CB; Berger K
    Health Secur; 2019; 17(2):83-99. PubMed ID: 30942632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Billions for biodefense: federal agency biodefense funding, FY2009-FY2010.
    Franco C
    Biosecur Bioterror; 2009 Sep; 7(3):291-309. PubMed ID: 19772453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing biosecurity threats in China.
    Huang Y
    Biosecur Bioterror; 2011 Mar; 9(1):31-40. PubMed ID: 21361794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening bioterrorism prevention: global biological materials management.
    Salerno RM; Hickok LT
    Biosecur Bioterror; 2007 Jun; 5(2):107-16. PubMed ID: 17608597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robert P. Kadlec, MD, former Special Assistant to the President and Senior Director for Biodefense Policy, Homeland Security Council. Interview by Madeline Drexler.
    Kadlec RP
    Biosecur Bioterror; 2009 Mar; 7(1):17-23. PubMed ID: 19379101
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosurveillance enterprise for operational awareness, a genomic-based approach for tracking pathogen virulence.
    Valdivia-Granda WA
    Virulence; 2013 Nov; 4(8):745-51. PubMed ID: 24152965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.
    Schuler A
    Biosecur Bioterror; 2005; 3(2):94-101. PubMed ID: 16000040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3LSI research: an essential element of biodefense.
    Green SK
    Biosecur Bioterror; 2005; 3(2):128-37. PubMed ID: 16000044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US biodefense--shocking and awful.
    Nat Biotechnol; 2007 Jun; 25(6):603. PubMed ID: 17557081
    [No Abstract]   [Full Text] [Related]  

  • 13. A shocking biodefense editorial.
    Vanderwagen WC
    Nat Biotechnol; 2007 Oct; 25(10):1083; author reply 1083-4. PubMed ID: 17921983
    [No Abstract]   [Full Text] [Related]  

  • 14. The four faces of microbial forensics.
    Tucker JB; Koblentz GD
    Biosecur Bioterror; 2009 Dec; 7(4):389-97. PubMed ID: 20028247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Web tools for predictive toxicology model building.
    Jeliazkova N
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):791-801. PubMed ID: 22577953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Publicly Available Landscape Analysis Tool for Biodefense Policy.
    Omberg KM; Franklin LR; Jackson DR; Taylor KL; Wahl KL; Lesperance A; Wynkoop EM; Gray JAS; Leiser OP; Frazar SL; Ozanich R; Bartholomew R
    Health Secur; 2018; 16(1):77-78. PubMed ID: 29350543
    [No Abstract]   [Full Text] [Related]  

  • 17. Billions for biodefense: federal agency biodefense funding, FY2001-FY2005.
    Schuler A
    Biosecur Bioterror; 2004; 2(2):86-96. PubMed ID: 15225402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of bioinformatics in translating huge amounts of next-generation sequencing data into personalized medicine.
    Hong H; Zhang W; Shen J; Su Z; Ning B; Han T; Perkins R; Shi L; Tong W
    Sci China Life Sci; 2013 Feb; 56(2):110-8. PubMed ID: 23393026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost/success projections for US biodefense countermeasure development.
    Matheny J; Mair M; Smith B
    Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies for biodefense.
    Froude JW; Stiles B; Pelat T; Thullier P
    MAbs; 2011; 3(6):517-27. PubMed ID: 22123065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.